Publications by authors named "Cesar Lopez Vejar"
Objective: We aimed to assess physical and psychosomatic manifestations of patients with long COVID and their association with a decreased patient's quality of life (QOL) or different times elapsed since the COVID-19 diagnosis.
Methods: This is a cross-sectional study. We retrospectively collected the clinical characteristics of adult patients who had tested positive for SARS-CoV-2 and had symptoms at least as early as 4 weeks after COVID-19 in México City between April 2020 and February 2021.
Article Synopsis
- - The adverse effects of sodium colistimethate, particularly nephrotoxicity and neurotoxicity, vary widely among patients and are influenced by antibiotic resistance issues as it is often used as a last-resort treatment.
- - The rising problem of multidrug-resistant bacteria has led to an increased reliance on colistin, yet there are no randomized clinical trials confirming its safety and efficacy, leaving dosing decisions largely based on expert opinions and observational studies.
- - This review aims to delve into the mechanisms behind nephrotoxicity and bacterial resistance related to colistin, highlighting that further research is needed in these areas.
Outpatient surveillance programme for health workers with COVID 19 in Mexico: an observational study of ambulatory treatment and early hospitalization.
Ther Adv Infect Dis
November 2022
Introduction: International guidelines recommend hospital care for patients with severe Coronavirus disease (COVID-19), but fragile health care systems struggle to cope with high number of admissions, placing patients at risk of receiving substandard care. We describe an outpatient ambulatory surveillance and treatment strategy (OPAT) for health care workers (HCWs) with severe COVID-19 during low hospital bed availability periods in Mexico City.
Methods: In this observational, descriptive, retrospective study, we included HCWs with severe disease for whom there were no hospital beds available at the time of evaluation.
Article Synopsis
- Invasive bladder Aspergillosis has been documented in only six cases, the first being in 1978 and the latest in 2020.
- A 74-year-old man presented with symptoms indicating a potential bladder tumor and was found to have a fungal mass caused by Aspergillus during cystoscopy.
- The patient was effectively treated with a 4-week course of oral Isavuconazole.
Background: We aimed to describe the use of drugs with apparent efficacy in ambulatory patients with confirmed COVID-19 and the relationship of Google Trends searches with prescriptions and the total number of COVID-19 cases in Mexico City.
Methods: Between March 2020 and February 2021, we surveyed 350 patients confirmed to have COVID-19 across 3 hospitals in Mexico City for their ambulatory prescriptions. We analysed the correlation between prescription patterns of 4 drugs with apparent efficacy against COVID-19, Google Trends searches for these drugs, and the overall number of confirmed COVID-19 cases in Mexico City.